drugset / Trial / NCT02768298
Exercise Capacity Study of LCZ696 vs. Enalapril in Patients With Chronic Heart Failure and Reduced Ejection Fraction.
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study was to determine the effect of LCZ696 vs. enalapril on improvement of exercise capacity in patients with chronic heart failure with reduced ejection fraction.
Timeline
- Start
- 2016-07-12
- Primary completion
- 2019-11-25
- Completion
- 2019-11-25
Outcome
Missed primary endpoint
registry analysis (superiority test); LCZ696 vs Enalapril; p = 0.2327; Least Squares (LS) Mean 0.32 (95% CI -0.21 to 0.85); ANCOVA NCT02768298 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Enalapril | Other / unclassified | 10 mg | Oral |
| Subject | LCZ696 | Unknown | 200 mg | Oral |